| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/02/2004 | CN1500789A Complex ML(DCA) of copper(ó�), gallium(ó¾) and rare earth ion(Ln**) containing non-methyl canthridic acid radical |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500514A Oral colon-positioned triperygium wilfordii composition and its use |
| 06/02/2004 | CN1500504A Medication for alimentary tract adenocarcinoma and its preparation method |
| 06/02/2004 | CN1500501A Compound traditional Chinese medicine formulation for curing hysteromyoma |
| 06/02/2004 | CN1500485A Solid dispersed matter of hydroxyl-camptothecin , its preparation and formulation |
| 06/02/2004 | CN1500479A resveratrol , piceid and its derivative and its preparation |
| 06/02/2004 | CN1152051C Trichosanthin mutant and preparing method thereof |
| 06/02/2004 | CN1152050C Cyclopeptide compound phakellistatin 12 with anticancer activity |
| 06/02/2004 | CN1152046C Betulinic acid derivatives, preparing method thereof and application in treating tumor related to angiogenesis |
| 06/02/2004 | CN1152044C C21 steriod glycoside extracted from cynanchum bunaei with antineoplastic function |
| 06/02/2004 | CN1152040C Carbazole derivatives, preparing process thereof and pharmaceutical combination containing the same |
| 06/02/2004 | CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 06/02/2004 | CN1152031C Isoquinoline derivatives with angiogenesis inhibiting activity |
| 06/02/2004 | CN1152023C Substituted polycyclic aryl and hetero aryl uracils as anticoagulant |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1152020C Benzimidazolrone and analogues, and uses as progesterone ligand thereof |
| 06/02/2004 | CN1152015C Piperazine devivatives and preparing method thereof |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/02/2004 | CN1152011C Vitamin D analogues and pharmaceutical uses thereof |
| 06/02/2004 | CN1151843C Novel anti-tumor medicine and its screening method and use |
| 06/02/2004 | CN1151841C Application of interferons(IFN) in preparation of pharmaceutics for stimulation of defence mechanism or immune reaction |
| 06/02/2004 | CN1151835C Medicine for treating tumor |
| 06/02/2004 | CN1151829C Medicine for treating lymphatic tuberculosis and lymphoma |
| 06/02/2004 | CN1151803C Prepared traditional Chinese medicine for treating cancer |
| 06/02/2004 | CN1151799C Bacterial membrane fractions with adjuvant effect |
| 06/02/2004 | CN1151797C Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/02/2004 | CN1151795C Drugs containing sulfopyranosylacylglycerol derivatives |
| 06/02/2004 | CN1151793C Medicinal composition for treating osseous lesion in multiple myeloma |
| 06/02/2004 | CN1151787C Lactacystine analogs |
| 06/01/2004 | US6743924 Method for producing 1-substituted-1,2,3-triazole derivative |
| 06/01/2004 | US6743919 2-aroylimidazole compounds for treating cancer |
| 06/01/2004 | US6743918 Process for producing camptothecin |
| 06/01/2004 | US6743908 For use in cancer diagnosis and therapy |
| 06/01/2004 | US6743896 Protien for use in the treatment of infection and tumors |
| 06/01/2004 | US6743826 Delivery of compounds having poor water solubility; binding affinity to plasma proteins by way of non-covalent bonds; serum albumin and gamma globulin; paclitaxel, amphotericin b, camptothecin, carbamazepine, cyclosporin a; propofol |
| 06/01/2004 | US6743824 Administering selegiline to patient in an amount sufficient to prevent, reduce or eliminate one or more of the symptoms associated with peripheral neuropathy |
| 06/01/2004 | US6743816 Imidazole derivatives with anti-inflammatory activity |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743794 Methods and compounds for inhibiting MRP1 |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743786 Vanadium compounds for treating cancer |
| 06/01/2004 | US6743785 Agents and methods for the treatment of proliferative diseases |
| 06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
| 06/01/2004 | US6743428 Angiogenesis inhibitor |
| 06/01/2004 | US6743412 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 06/01/2004 | CA2321542C Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated "agelagalastatin" |
| 06/01/2004 | CA2270004C Stable mitoxantrone solutions |
| 06/01/2004 | CA2266016C Tricyclic inhibitors of farnesyl protein transferase |
| 06/01/2004 | CA2196922C Pharmaceutically stable oxaliplatinum preparation |
| 06/01/2004 | CA2170605C Mutants of the rb and p53 genes and uses thereof |
| 05/27/2004 | WO2004044590A1 Tumour marker proteins and uses thereof |
| 05/27/2004 | WO2004044229A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004043994A2 A retro-inverso gonadotropin-releasing hormone peptide and vaccine composition |
| 05/27/2004 | WO2004043993A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 05/27/2004 | WO2004043982A2 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 05/27/2004 | WO2004043975A1 Palladium complexes with heterocyclic ligands |
| 05/27/2004 | WO2004043963A1 Pyrrolobenzodiazepines |
| 05/27/2004 | WO2004043962A1 4-AMINO-5-PHENYL-7-CYCLOHEXYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES |
| 05/27/2004 | WO2004043956A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 05/27/2004 | WO2004043955A1 Rhodanine derivatives and pharmaceutical compositions containing them |
| 05/27/2004 | WO2004043953A1 Pyrimidine compounds |
| 05/27/2004 | WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043936A1 Plk inhibitors |
| 05/27/2004 | WO2004043907A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/27/2004 | WO2004043487A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface |
| 05/27/2004 | WO2004043472A1 Combination product of inhibitor of the src family of non-receptor tyrosine kinases and gemcitabine |
| 05/27/2004 | WO2004043466A1 Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia |
| 05/27/2004 | WO2004043459A1 Treatment of mesothelioma |
| 05/27/2004 | WO2004043454A1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents |
| 05/27/2004 | WO2004043449A1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 05/27/2004 | WO2004043448A1 Pharmaceutical pellets comprising tamsulosin |
| 05/27/2004 | WO2004043428A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/27/2004 | WO2004043389A2 Methods of treating cancer and related methods |
| 05/27/2004 | WO2004043232A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004043222A2 Treating carcinoid neoplasms with therapeuthic viruses |
| 05/27/2004 | WO2004035616A3 Adenovirus expressing genes in reverse order and use thereof |
| 05/27/2004 | WO2004033696A3 Recombinant adenoviral vectors and applications thereof |
| 05/27/2004 | WO2004017959A3 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 05/27/2004 | WO2004008147A3 Diagnosis and prevention of cancer cell invasion |
| 05/27/2004 | WO2004006842A3 Combinations of drugs for the treatment of neoplasms |
| 05/27/2004 | WO2003099812A8 Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003070245B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 05/27/2004 | WO2003061589A3 Methods for treating diseases or conditions with peptide constructs |
| 05/27/2004 | WO2003059276B1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 05/27/2004 | WO2003045229A3 Methods and compositions for treating cancer |
| 05/27/2004 | WO2003044183A8 Interleukin-2 gene transferred lymphokine activated killer cells |
| 05/27/2004 | WO2003033006A8 Extract of ceratonia siliqua leaves and pods containing polyphenols with antioxidant and antitumor activities |
| 05/27/2004 | WO2003025177A3 Sequences involved in phenomena of tumour suppression, tumour reversion, adoptosis and/or resistance to viruses and the use thereof as medicaments |
| 05/27/2004 | WO2003015705A3 In situ immunization |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | WO2003006036A3 Herbal formulation |